A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
Clinical trial NCT06834932 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06834932
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-06
- Primary completion
- 2027-02-22
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.